Vivo Bio Tech Ltd Financial Ratios
VIVOBIOT · Healthcare · Current price ₹23.48
P/E ratio
5.5x
P/B ratio
0.6x
ROE
-2.0%
ROCE
9.0%
Debt / Equity
0.72
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 5.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.6x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -2.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 9.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.72 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Vivo Bio Tech Ltd's latest numbers.
Vivo Bio Tech Ltd profitability
Vivo Bio Tech Ltd generates a return on equity of -2.0% and a return on capital employed of 9.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.72 and a P/E of 5.5x, Vivo Bio Tech Ltd is moderately leveraged. Our overall business-quality score for the company is 3.7 / 10.
Understand the ratios
More on Vivo Bio Tech Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.